NIAB EMR and Meiosis announce new collaborative working relationship
The agreement gives NIAB EMR immediate worldwide control and management of all current and future marketing and licensing rights for the varieties which to date had been managed by Meiosis. Instead, the parties will together explore licencing opportunities in countries further afield, not currently growing varieties from the Malling berry breeding programmes. To support this transition, Meiosis will continue the role of royalty collection for a fixed period of time.